• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care - Gottlieb's Hearing for FDA, and Other News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included Scott Gottlieb, MD, the nominee to lead the FDA, testifying before a Senate panel as part of his confirmation process; a rough week for Mylan with an EpiPen recall and a class-action lawsuit; and a new study that tied late nights to depression for people with diabetes.

Listen below or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Related Videos
Dr Marco del Riccio
Dr Marco del Riccio
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Marry Vuong, PharmD, BCPPS
Dr Elise Tremblay
Dr Elise Tremblay
Marry Vuong, PharmD, BCPPS
Dr Elise Tremblay
Marry Vuong, PharmD, BCPPS
Related Content
Older woman interacts with smart speaker technology | Image credit: Vadim Pastuh - stock.adobe.com

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes

January 23rd 2026
Article

A randomized clinical trial found a voice-enabled virtual assistant reduced mental distress and improved quality of life, self-care, and glycemic control.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg

SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs

January 21st 2026
Article

Initiating SGLT2is was linked to lower risks of chronic kidney disease and fewer acute kidney injury events than GLP-1 RAs in metformin-treated type 2 diabetes.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Diabetes monitoring | Image credit: abidika - stock.adobe.com

How EHRs Help Identify Diabetes Risk in Families of Adults With Prediabetes

January 13th 2026
Article

Recent findings support the use of EHRs not only for individual patient care but also for family-centered interventions to curb the growing diabetes epidemic.

Read More

AJMC original research clinical

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

December 22nd 2025
Article

A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.